The company aims to more than double its revenue from the health science division to 20% of total in about 10 years, its President and Chief Operating Officer
Growing the company’s current businesses, including Fancl, will be the “first priority” to boost revenue, he said, adding that there will be limitations to how ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
